BioCentury
ARTICLE | Company News

Amarillo, Cyto Biotech Co. Ltd. deal

March 9, 2009 7:00 AM UTC

Cyto Biotech received an exclusive, worldwide license, excluding China and Taiwan, to develop and commercialize Amarillo's low dose oral interferon for all indications. Cyto Biotech has non-exclusive ...